SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising -- Ignore unavailable to you. Want to Upgrade?


To: IRWIN JAMES FRANKEL who wrote (3616)8/20/1999 12:21:00 AM
From: Bob Swift  Read Replies (2) | Respond to of 10280
 
IJF,
Where did you hear that from ? Seems like we bitched and moaned about them not spending enough money in marketing and they are doing something. Let's bitch about not getting more news announced.



To: IRWIN JAMES FRANKEL who wrote (3616)8/20/1999 7:54:00 AM
From: BMcV  Read Replies (1) | Respond to of 10280
 
ij,

is the 14% market share for Xopenex for new prescriptions only?

Otherwise, the number is way too high. There were $5 million in Xopenex sales last quarter; Albuterol is a billion plus drug.